Unusual results from immunoassays and the role of the clinical endocrinologist

Clinical Endocrinology

Volumn 64, Issue 3, 2006, Pages 234-244

  Jones, Alison M ^a   Honour, John W ^a  

^a UNIVERSITY COLLEGE LONDON HOSPITALS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; AMIODARONE; ANTICOAGULANT AGENT; AUTOANTIBODY; CALCITONIN; CHORIONIC GONADOTROPIN; CHORIONIC GONADOTROPIN BETA SUBUNIT; DIGOXIN; EDETIC ACID; HEPARIN; HYDROCORTISONE; INSULIN; LUTEINIZING HORMONE; ORAL CONTRACEPTIVE AGENT; PROLACTIN; PROSTATE SPECIFIC ANTIGEN; RADIOISOTOPE; TESTOSTERONE; THYROID HORMONE; TROPONIN;

ANTIBODY SPECIFICITY; BLOOD ANALYSIS; CIRCADIAN RHYTHM; DIAGNOSTIC REASONING; ENDOCRINOLOGY; HORMONE DETERMINATION; HUMAN; IMMUNOASSAY; MEDICAL SPECIALIST; MENSTRUAL CYCLE; PREGNANCY; PRIORITY JOURNAL; QUALITY CONTROL; REVIEW; SAMPLING; SIGNAL NOISE RATIO;

ANIMALS; ANTIBODIES; ANTIBODY SPECIFICITY; AUTOANTIBODIES; BLOOD CHEMICAL ANALYSIS; BLOOD PROTEINS; ENDOCRINOLOGY; HORMONES; HUMANS; IMMUNOASSAY; PHYSICIAN'S ROLE; PLASMA; SERUM;

EID: 33644942528     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02439.x     Document Type: Review

References (145)

1. Weber T.H. Kapyaho K.I. Tanner P. 1990 Endogenous interference in immunoassays in clinical chemistry. A review Scandinavian Journal of Clinical Laboratory Investigation 50 Suppl. 201 77 82
2. Rotmensch S. Cole L.A. 2000 False diagnosis and needless therapy of presumed malignant disease in women with false-positive human chorionic gonadotropin concentrations Lancet 355 712 715
3. Cole L.A. 1998 Phantom hCG and phantom choriocarcinoma Gynecological Oncology 71 325 329
4. Cole L.A. Rinne K.M. Shahabi S. Omrani A. 1999 False-positive hCG assay results leading to unnecessary surgery and chemotherapy and needless occurrences of diabetes and coma Clinical Chemistry 45 313 314
5. Tommasi M. Brocchi A. Cappellini A. Raspanti S. Mannelli M. 2001 False serum calcitonin high levels using a non-competitive two-site IRMA Journal of Endrocrinological Investigation 24 356 360
6. Ismail A.A. Walker P.L. Fahie-Wilson M.N. Jassam N. Barth J.H. 2003 Prolactin and macroprolactin: a case report of hyperprolactinaemia highlighting the interpretation of discrepant results Annals of Clinical Biochemistry 40 298 300
7. John R. McDowell I.F. Scanlon M.F. Ellis R.R. 2000 Macroprolactin reactivities in prolactin assays: an issue for clinical laboratories and equipment manufacturers Clinical Chemistry 46 884 885
8. Sapin R. Simon C. 2001 False hyperprolactinaemia corrected by the use of heterophilic antibody-blocking agent Clinical Chemistry 47 2184 2185
9. Kelly C.J.K. Ogilvie A. Evans J.R. Shapiro D. Wallace A.M. Davies D.L. 2001 Raised cortisol excretion rate in urine and contamination by topical steroids British Medical Journal 322 594
10. 125I] testosterone in patient's serum: a problem for the laboratory and the patient Clinical Chemistry 42 2047 2048
11. O'Reilly S.M. Rustin G.J.S. 1993 Mismanagement of choriocarcinoma due to a false low HGC measurement International Journal of Gynecological Cancer 3 186 188
12. Steimer W. Muller C. Eber B. Emmanuilids K. 1999 Intoxication due to negative canrenone interference in digoxin drug monitoring Lancet 354 1176 1177
13. Valdes R. Jortani S.A. 2002 Unexpected suppression of immunoassay results by cross-reactivity: now a demonstrated cause for concern Clinical Chemistry 48 405 406
14. Ismail A.A.A. Walker P.L. Barth J.H. Lewandowski C. Jones R. Burr W.A. 2002 Wrong biochemistry results: two case reports and observational study in 5310 patients on potentially misleading thyroid-stimulating hormone and gonadotropin immunoassay results Clinical Chemistry 48 2023 2029
15. Koning C.H. Popp-Snijders C. Martens F. Lambalk C.B. 2000 Falsely elevated follicle-stimulating hormone levels in women with regular menstrual cycles due to interference in immunoradiometric assay Journal of Assisted Reproduction and Genetics 17 457 459
16. Marks V. 2002 False-positive immunoassay results: a multicenter survey of erroneous immunoassay results from assays of 74 analytes in 10 donors from 66 laboratories in seven countries Clinical Chemistry 48 2008 2016
17. Cusick C.F. Mistry K. Addison G.M. 1985 Interference in a two-site immunoradiometric assay for thyrotropin in a child Clinical Chemistry 31 348 349
18. Landau-Levine M. Way B.A. Clutter W.E. Scott M.G. Gronowski A.M. 1999 Antibody interference with the Abbott AxSym immunoassay for thyroid-stimulating hormone Clinica Chimica Acta 281 177 180
19. Krahn J. Parry D.M. Leroux M. Dalton J. 1999 High percentage of false positive cardiac troponin I results in patients with rheumatoid factor Clinical Biochemistry 32 477 480
20. Plebani M. Mion M. Altinier S. Girotto M.A. Baldo G. Zaninotto M. 2002 False positive troponin I attributed to a macrocomplex Clinical Chemistry 48 677 678
21. Covinsky M. Laterza O. Pfeifer J.D. Farkas-Szallasi T. Scott M.G. 2000 An IgM antibody to Escherichia coli produces false-positive results in multiple immunometric assays Clinical Chemistry 46 1157 1161
22. Knoblock R.J. Lehman C.M. Smith R.A. Apple F.S. Roberts W.L. 2002 False-positive AxSym cardiac troponin I results in a 53-year-old woman Archives of Pathological Medicine 126 606 609
23. Bohner J. von Pape K.-W. Hannes W. Stegman T. 1996 False-negative immunoassay results for cardiac troponin I probably due to circulating troponin I antibodies Clinical Chemistry 42 2046
24. Binkley N. Krueger D. Cowgill C.S. Plum L. Lake E. Hansen K.E. deLuca H.F. Drezner M.K. 2004 Assay variation confounds the diagnosis of hypovitaminosis D: a call for standardization Journal of Clinical Endocrinology and Metabolism 89 3152 3157
25. Despres N. Grant A.M. 1998 Antibody interference in thyroid assays: a potential for clinical misinformation Clinical Chemistry 44 440 454
26. Hollis B.W. 2004 The determination of circulating 25-hydroxyvitamin D: no easy task Journal of Clinical Endocrinology and Metabolism 89 3149 3151
27. Ismail A.A. 2005 A radical approach is needed to eliminate interference from endogenous antibodies in immunoassays Clinical Chemistry 51 9 11
28. Taieb J. Benattar C. Birr A.S. Lindenbaum A. Frydman R. Olivenness F. 2000 Delayed assessment of serum and whole blood estradiol, progesterone, follicle-stimulating hormone, and luteinizing hormone kept at room temperature or refrigerated Fertility and Sterility 74 1053 1054
29. Licciardi F.L. Liu H.-C. Rosenwaks Z. 1995 Day 3 estradiol serum concentrations as prognosticators of ovarian stimulation response and pregnancy outcome in patients undergoing in vitro fertilization Fertility and Sterility 64 991 994
30. Ismail A.A. Cawood M. Ufodiama E.B. Jones S.T. 2004 Limitations of 17-hydroxyprogesterone in investigating neonatal hyponatraemia Annals of Clinical Biochemistry 41 245 247
31. Wilde C. 2004 Subject preparation, sample collection and handling In Wild D. The Immunoassay Handbook Elsevier Wild D.
32. Elmlinger M.W. Kuhnel W. Ranke M.B. 2002 Reference ranges for serum concentrations of lutropin (LH), follitropin (FSH), prolactin, progesterone, sex hormone binding globulin (SHBG), dehydroepiandrosterone sulphate (DHEAS), cortisol and ferritin in neonates, children and young adults Clinical Chemistry and Laboratory Medicine 40 1131 1160
33. Elmlinger M.W. Dengler T. Weinstock C. Kuehnel W. 2003 Endocrine changes in the aging male Clinical Chemistry and Laboratory Medicine 41 934 941
34. Burger H.G. Dudley E.C. Cui J. Dennerstein L. Hopper J.L. 2000 A prospective study of serum testosterone, dehydroepiandrosterone sulphate and sex-hormone binding globulin levels through the menopause transition Journal of Clinical Endocrinology and Metabolism 85 2832 2838
35. Tejada F. Cremades A. Monserrat F. Penafiel R. 1998 Interference of the antihormone RU468 in the determination of testosterone and estradiol by enzyme-immunoassay Clinica Chimica Acta 275 63 69
36. Cummings E.A. Salisbury S.R. Givner M.L. Rittmaster R.S. 1998 Testolactone-associated high androgen levels, a pharmacologic effect or a laboratory artefact? Journal of Clinical Endocrinology and Metabolism 83 784 787
37. Lee C. Goeger D.E. 1998 Interference of 6β-hydroxycortisol in the quantitation of urinary free cortisol by immunoassay and its elimination by solid phase extraction Clinical Biochemistry 31 229 233
38. Fink R.S. Pierre L.N. Daley-Yates P.T. Richards D.H. Gibson A. Honour J.W. 2002 Hypothalamic-pituitary-adrenal axis function after inhaled corticosteroids: unreliability of urinary free cortisol estimation Journal of Clinical Endocrinology and Metabolism 87 4541 4546
39. Tera I. Yamano K. Ichihara N. Arai J. Kobayashi K. 1999 Influence of spironolactone on neonatal screening for congenital adrenal hyperplasia Archives of Disease in ChildhoodFetal Neonatal Edition 81 F179 F183
40. Laji K. Rhidha B. John R. Lazarus J. Davies J.S. 2001 Abnormal serum free thyroid hormone levels due to heparin administration Quarterly Journal of Medicine 94 471 473
41. Henry J.G. Sobki S. Arafat N. 1996 Interference by biotin therapy on measurement of TSH and FT4 by enzymeimmunoassay on Boehringer Mannheim ES700 analyser Annals of Clinical Biochemistry 33 162 163
42. Selby C. 1999 Interference in immunoassay Annals of Clinical Biochemistry 36 704 721
43. Bowie L.J. Kirkpatrick P.B. Dohnal J.C. 1987 Thyroid function testing with the TDx: interference from endogenous fluorophore Clinical Chemistry 33 1467
44. Inloes R. Clark D. Drobnies A. 1987 Interference of fluorescein, used in retinal angiography, with certain clinical laboratory tests Clinical Chemistry 33 2126 2127
45. Arano Y. 1999 Delivery of diagnostic agents for gamma-imaging Advanced Drug Delivery Reviews 37 103 120
46. Bowen R.A.R. Chan Y. Cohen J. Rehak N.N. Hortin G.L. Csako G. Remaley A.T. 2005 Effect of blood collection tube on total triiodothyronine and other laboratory assays Clinical Chemistry 51 424 433
47. Wood W.G. 1991 'Matrix effects' in immunoassays Scandinavian Journal of Clinical Laboratory Investigation 51 Suppl. 205 105 112
48. Thirunavukarasu P.P. Wallace E.M. 2001 Measurement of inhibin A: a modification to an enzyme-linked immunosorbent assay Prenatal Diagnosis 21 638 641
49. Martin I. Gilbert M.J. Vila M. Pintos C. Obrador A. Malo O. 2001 Stabilization of blood homocysteine in an epidemiological setting European Journal of Cancer Prevention 10 473 476
50. Hill D.M. Johnson L.J. Burns P.J. Neale A.M. Harmening D.M. Kenney A.C. 2002 Effects of temperature on stability of blood homocysteine in collection tubes containing 3-deazaadenosine Clinical Chemistry 48 2017 2022
51. Reyna R. Trayner K.D. Hines G. Boots L.R. Azziz R. 2001 Repeated freezing and thawing does not generally alter assay results for several commonly studied reproductive hormones Fertility and Sterility 76 823 825
52. Evans M.J. Livesey J.H. Ellis M.J. Yandle T.G. 2001 Effect of anticoagulants and storage temperatures on stability of plasma and serum hormones Clinical Biochemistry 34 107 112
53. Kohek M.B. Leme C.R. Nakamura I.T. De Oliveira S.A. Lando V. Mendonca B.B. 2002 Effects of EDTA and sodium citrate on hormone measurements by fluorometric (FIA) and immunofluorometric (IFMA) methods BMC Clinical Pathology 2 2 5
54. Zweig M.H. Glickman J. Csako G. 1994 Analytical interference caused by incompletely clotted serum specimens Clinical Chemistry 40 2325 2326
55. Omar H. Chamberlin A. Walker V. Wood P.J. 2001 Immulite 2000 parathyroid hormone assay: stability of parathyroid hormone in EDTA blood kept at room temperature for 48 h Annals of Clinical Biochemistry 38 561 563
56. Holmes D.T. Levin A. Forer B. Rosenberg F. 2005 Preanalytical influences on DPC Immulite 2000 intact PTH assays of plasma and serum from dialysis patients Clinical Chemistry 51 915 917
57. Chang C.-Y. Lu J.-Y. Chein T.-I. Kao J.-T. Lin M.-C. Shih P.-C. Yan S.-N. 2003 Interference caused by the contents of serum separator tubes in the Vitros CRP assay Annals of Clinical Biochemistry 40 249 251
58. Wenk R.E. 1998 Mechanism of interference by hemolysis in immunoassays and requirements for sample quality Clinical Chemistry 44 2554
59. Nishikawa M. Ogawa Y. Yoshikawa N. Yoshimura M. Toyoda N. Shouza A. Inada M. 1996 Plasma free thyroxine (FT4) concentrations during haemodialysis in patients with chronic renal failure: effects of plasma non-esterified fatty acids on FT4 measurement Endocrine Journal 43 487 493
60. Liewendahl K. Tikanoja S. Mahonen H. Helenius T. Valimaki M. Tallgren L.G. 1987 Concentration of iodothyronines in serum of patients with chronic renal failure and other nonthyroidal illnesses: role of free fatty acids Clinical Chemistry 33 1382 1386
61. Csako G. Zwieg M.H. Glickman J. Kestner J. Ruddel M. 1989 Direct and indirect techniques for free thyroxin compared in patients with nonthyroidal illness: I. Effect of free fatty acids Clinical Chemistry 35 102 109
62. Rash J.M. Jerkunica I. Sgoutas D.S. 1980 Lipid interference in steroid radioimmunoassay Clinical Chemistry 26 84 88
63. Fisker S. Edrup L. Orskov H. 1998 Influence of growth hormone binding protein on growth hormone estimation in different immunoassays Scandinavian Journal of Clinical Laboratory Investigation 58 373 381
64. Linton E.A. Perkins A.V. Hagan P. Poole S. Bristow A.F. Tilders F. Corder R. Wolfe C.D. 1995 Corticotrophin-releasing hormone (CRH)-binding protein interference with CRH antibody binding; implications for direct CRH immunoassay Journal of Endocrinology 146 45 53
65. Ekins R. 1960 Measurement of free hormones in blood Endocrine Reviews 11 5 46
66. Christofides N.D. 1999 Furosemide interference in newer free thyroxine assays Clinical Chemistry 45 1315
67. Hawkins R.C. 1998 Furosemide interference in newer free thyroxine assays Clinical Chemistry 44 2550 2551
68. Kroll M.H. Elin R.J. 1994 Interference with clinical laboratory analyses Clinical Chemistry 40 1996 2005
69. Gallou G. Legras B. Ruelland A. Grosbois B. Cloarec L. 1993 Problems of C-reactive protein determination in patients with monoclonal immunoglobulins Clinical Chemistry 39 918
70. Granouillet R. Rascle F. Bonneau C. Cahmson A. Frey J. Perier C. 1999 Evidence of temperature dependent interference in an immunonephelometric assay by monoclonal IgM Clinical Chemistry 45 2039 2040
71. Lammers M. 1998 Interference with nephelometric assay of C-reactive protein by monoclonal immunoglobulin Clinical Chemistry 44 1584 1585
72. Yamada K. Yagihashi A. Ishii S. Tanemura K. Kida T. Wanabe N. Niitsu Y. 1997 Interference with nephelometric assay of C-reactive protein and antistreptolysin-O by monoclonal IgM-k from a myeloma patient Clinical Chemistry 43 2345 2347
73. Ismail A.A. Walker P.L. Cawood M.L. Barth J.H. 2002 Interference in immunoassay is an underestimated problem Annals of Clinical Biochemistry 39 366 373
74. Preissner C.M. O'Kane D.J. Singh R. Morris J.C. Grebe S.K. 2003 Phantoms in the assay tube: heterophilic antibody interferences in serum thyroglobulin assays Journal of Clinical Endocrinology and Metabolism 88 3069 3074
75. Levinson S.S. 1992 Antibody multispecificity in immunoassay interference Clinical Biochemistry 25 77 87
76. Norden A.G. Jackson R.A. Norden L.E. Griffin A.J. Barnes M.A. Little J.A. 1997 Misleading results from immunoassays of serum free thyroxine in the presence of rheumatoid factor Clinical Chemistry 43 957 962
77. Boscato L.M. Stuart M.C. 1986 Incidence and specificity of interference in two-site immunoassays Clinical Chemistry 32 491 495
78. Kricka L.J. Schmerfeld-Pruss D. Senior M. Goodman D.B. Kaladas P. 1990 Interference by human anti-mouse antibody in two-site immunoassays Clinical Chemistry 36 892 894
79. Kricka L.J. 1999 Human anti-animal antibody interferences in immunological assays Clinical Chemistry 45 942 956
80. Boerman O.C. Segers M.F. Poels L.G. Kenemans P. Thomas C.M.G. 1990 Heterophilic antibodies in human sera causing falsely increased results in the CA 125 immunofluorimetric assay Clinical Chemistry 36 888 891
81. Turpeinen U. Lehtovirta P. Alfthan H. Stenman U.-H. 1990 Interference by human anti-mouse antibodies in CA 125 assay after immunoscintography: anti-idiotypic antibodies not neutralized by mouse IgG but removed by chromatography Clinical Chemistry 36 1333 1338
82. Turpeinen U. Lehtovirta P. Stenman U.-H. 1995 CA 125 determined by three methods in samples from patients with human anti-mouse antibodies (HAMA) Clinical Chemistry 41 1667 1669
83. Revelen R. Bordron A. Dueymes M. Youinou P. Arvieux J. 2000 False positivity in a cyto-ELISA for anti-endothelial cell antibodies caused by heterophile antibodies to bovine serum proteins Clinical Chemistry 46 273 278
84. Koper N.P. Massuger L.F. Thomas C.M. Beyer C. Crooy M.J. 1999 An illustration of the clinical relevance of detecting human antimouse antibody interference by affinity chromatography European Journal of Obstetrics, Gynecology, and Reproductive Biology 86 203 205
85. Kaplan I.V. Levinson S.S. 1999 When is a heterophile antibody not a heterophile antibody? When it is an antibody against a specific immunogen Clinical Chemistry 45 616 618
86. Hoffman T. 1990 Anticipating, recognizing, and preventing hazards associated with in vivo use of monoclonal antibodies: special considerations related to human anti-mouse antibodies Cancer Research 50 1049s 1050s
87. Levinson S.S. Miller J.J. 2002 Towards a better understanding of heterophile (and the like) antibody interference with modern immunoassays Clinica Chimica Acta 325 1 15
88. Mariotti S. Barbesino G. Caturegli P. Marino P. Manetti L. Pacini F. Centoni R. Pinchera A. 1995 Assay of thyroglobulin in serum with thyroglobulin autoantibodies: an unobtainable goal? Journal of Clinical Endocrinology and Metabolism 80 468 472
89. Spencer C.A. Takeuchi M. Kazarosyan M. 1996 Current status and performance goals for serum thyroglobulin assays Clinical Chemistry 42 164 173
90. Spencer C.A. Takeuchi M. Kazarosyan M. Wang C.C. Guttler R.B. Singer P.A. Fatemi S. LoPresti J.S. Nicoloff J.T. 1998 Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurements, and prognostic significance in patients with differentiated thyroid carcinoma Journal of Clinical Endocrinology and Metabolism 83 1121 1127
91. Dai J. Dent W. Atkinson J.W. Cox J.G. Dembinski T.C. 1996 Comparison of three immunoassay kits for serum thyroglobulin in patients with thyroid cancer Clinical Biochemistry 29 461 465
92. Byfield P.G. Clingan D. Himsworth R.L. 1985 Structural basis for the reaction of 3,5,3′-tri-iodothyronine-specific antibodies with thyroxine-containing thyroglobulin Biochemical Journal 228 155 160
93. Sakata S. Nakamura S. Miura K. 1985 Autoantibodies against thyroid hormones or iodothyronine Annals of Internal Medicine 103 579 589
94. Ismail A.A. Barth J.H. 2001 Wrong biochemistry results British Medical Journal 323 705 706
95. Dasgupta A. Wells A. Datta P. 1999 Effect of digoxin Fab antibody on the measurement of total and free digitoxin by fluorescence polarization and a new chemiluminescent immunoassay Therapeutic Drug Monitoring 21 251 255
96. Thompson R.J. Jackson A.P. Langlois N. 1986 Circulating antibodies to mouse monoclonal immunoglobulins in normal subjects - incidence, species specificity, and effects on two-site assay for creatine kinase-MB isoenzyme Clinical Chemistry 32 476 481
97. Bjerner J. Nustad K. Norum L.F. Olsen K.H. Bormer O.P. 2002 Immunometric assay interference: incidence and prevention Clinical Chemistry 48 613 621
98. Ward G. McKinnon L. Badrick T. Hickman P.E. 1997 Heterophilic antibodies remain a problem for the immunoassay laboratory American Journal of Clinical Pathology 108 417 421
99. Vezzosi D. Benet A. Fauvel J. Boulanger C. Tazi O. Louvet J.P. Caron P. 2003 Insulin levels measured with an insulin specific assay in patients with fasting hypoglycaemia related to endogenous hyperinsulinism European Journal of Endocrinology 149 413 419
100. Nakanishi S. Kazama J.J. Shigematsu T. Iwasaki Y. Cantor T.L. Kurosawa T. Fukagawa M. 2001 Comparison of intact PTH assay and whole PTH assay in long-term dialysis patients American Journal of Kidney Disease 38 S172 S174
101. Iles R.K. Javid M.K. Gunn L.K. Chard T. 1999 Cross-reaction with luteinizing hormone β-core is responsible for the age-dependent increase of immunoreactive β-core fragment of human chorionic gonadotropin in women with nonmalignant conditions Clinical Chemistry 45 532 538
102. O'Connor J.F. Kovalevskya G. Birken S. 1999 Interference of luteinizing hormone β-core fragment in urinary gonadotropin assays Clinical Chemistry 45 2290 2292
103. Cole L.A. 1997 Immunoassay of human chorionic gonadotropin, its free subunits, and metabolites Clinical Chemistry 43 2233 2243
104. Cole L.A. Kardana A. 1992 Discordant results in human chorionic gonadotropin assays Clinical Chemistry 38 263 270
105. Stenman U.-H. Unkila-Kallio L. Korhonen J. Alfthan H. 1997 Immunoprocedures for detecting human chorionic gonadotropin: clinical aspects and doping control Clinical Chemistry 43 1293 1298
106. Bagshawe K.D. 2000 Limitations of tests for human chorionic gonadotropin Lancet 355 671
107. Bowsher R.R. Apathy J.M. Ferguson A.L. Riggin R.M. Henry D.P. 1990 Cross-reactivity of monomeric and dimeric biosynthetic human growth hormone in commercial immunoassays Clinical Chemistry 36 362 366
108. Rajkhowa M. Talbot J.A. Jones P.W. Pettersson K. Haavisto A.M. Huhtaniemi I. Clayton R.N. 1995 Prevalence of an immunological LH β-subunit variant in a UK population of healthy women and women with polycystic ovary syndrome Clinical Endocrinology 43 297 303
109. Furui K. Suganuma N. Tsukahara S.-I. Asada Y. Kikkawa F. Tanaka M. Ozawa T. Tomoda Y. 1994 Identification of two point mutations in the gene coding luteinizing hormone (LH) β-subunit, associated with immunologically anomalous LH variants Journal of Clinical Endocrinology and Metabolism 78 107 113
110. Madersbacher S. Berger P. 2000 Antibodies and immunoassays Methods 21 41 50
111. Helander A. Eriksson G. Stibler H. Jeppsson J.-O. 2001 Interference of transferrin isoform types with carbohydrate-deficient transferrin quantification in the identification of alcohol abuse Clinical Chemistry 47 1225 1233
112. Jones J.C. Macgregor G.A. 1981 Interference by polar metabolites in a direct radioimmunoassay for plasma aldosterone Annals of Clinical Biochemistry 18 54 59
113. Smith T.P. Suliman A.M. Fahie-Wilson M.N. McKenna T.J. 2002 Gross variability in the detection of prolactin in sera containing big big prolactin (macroprolactin) by commercial immunoassays Journal of Clinical Endocrinology and Metabolism 87 5410 5415
114. Gilson G. Schmidt P. Thix J. Hoffman J.T. Humbel L. 2001 Prolactin results for samples containing macroprolactin are method and sample dependent Clinical Chemistry 47 331 333
115. Huang C.M. Zweig M. 1989 Evaluation of a radioimmunoassay of urinary cortisol without extraction Clinical Chemistry 35 125 126
116. Perry B. Chapman R.S. McConway M.G. Griffin D. Beastell G.H. 1991 Specificity of two-site immunometric assays Annals of Clinical Biochemistry 28 83 86
117. Krishna R.V. Meurman O.H. Ziegler T. Krech U.H. 1980 Solid-phase enzyme immunoassay for determination of antibodies to cytomegalovirus Journal of Clinical Microbiology 12 46 51
118. Butler J. 1995 Negative interference in immunoassays Clinical Chemistry 41 481 482
119. Hampton S.M. Beyzavi K. Teale D. Marks V. 1988 A direct assay for proinsulin in plasma and its applications in hypoglycaemia Clinical Endocrinology 29 9 16
120. Kao P.C. Taylor R.L. Service J.F. 1994 Proinsulin by immunochemiluminometric assay for the diagnosis of insulinoma Journal of Clinical Endocrinology and Metabolism 78 1048 1051
121. Shimizu T. Sasakuma F. Ishikawa O. Matsumiya K. Hasegawa K. Sasaki A. 1994 Assessment of immunoassays for insulin in diagnostic tests for insulinoma Diabetes Research and Clinical Practice 26 149 154
122. Madersbacher S. Klieber R. Mann K. Marth C. Tabarelli M. Wick G. Berger P. 1992 Free α-subunit, free β-subunit of human chorionic gonadotropin (hCG), and intact hCG in sera of healthy individuals and testicular cancer patients Clinical Chemistry 38 370 376
123. Berger P. Schwarz S. Spottl G. Wick G. Mann K. 1993 Variants of human chorionic gonadotropin from pregnant women and tumor patients recognized by monoclonal antibodies Journal of Clinical Endocrinology and Metabolism 77 347 351
124. Rinne K. Shahabi S. Cole L. 1999 Following metastatic placental site trophoblastic tumor with urine β-core fragment Gynecological Oncology 74 302 303
125. Jones R.G. Barth J.H. Mitchell H. 1999 Tumour markers: same marker, different assay, different result Clinical Oncology 11 221 222
126. Vaidya H.C. Wolf B.A. Garrett N. Calalona W.J. Clayman R.V. Nahm M.H. 1988 Extremely high values of prostate-specific antigen in patients with adenocarcinoma of the prostate; demonstration of the 'hook effect.' Clinical Chemistry 34 2175 2177
127. Bodor G. Wolf B.A. Hinds B. Nahm M.H. Scott M.G. 1989 More on 'hook effects' in immunometric assays for prostate-specific antigen Clinical Chemistry 35 1262 1263
128. Alfthan H. Stenman U.-H. 1988 Falsely low results obtained with the Hybritech Tandem-R PSA assay Clinical Chemistry 34 2152
129. Charrie A. Charriere G. Guerrier A. 1995 Hook effect in immunometric assays for prostate-specific antigen Clinical Chemistry 41 480 481
130. Haller B.L. Fuller K.A. Brown W.S. Koenig J.W. Eveland B.J. Scott M.G. 1992 Two automated prolactin immunoassays evaluated with demonstration of a high-dose 'hook effect' in one Clinical Chemistry 38 437 438
131. Leape L.L. 2002 Striving for perfection Clinical Chemistry 48 1871 1872
132. Kricka L.J. 2004 Interferences in immunoassay - still a threat Clinical Chemistry 46 1037 1038
133. Wickus G.G. Caplan R.H. Mathews E.A. Pehling G.B. 1991 Sudden appearance and subsequent disappearance of interference in immunometric assays of thyrotropin neutralizable with purified mouse IgG Clinical Chemistry 37 595 596
134. Emerson J.F. Ngo G. Emerson S.S. 2003 Screening for interference in immunoassays Clinical Chemistry 49 1163 1169
135. Span P.N. Grebenchtchikov N. Geurts-Moespot J. Sweep C.G. 2003 Screening for interference in immunoassays Clinical Chemistry 49 1708 1709
136. Butch A.W. 2000 Dilution protocols for detection of hook effects/prozone phenomenon Clinical Chemistry 46 1719 1720
137. Liendo C. Ghali J. Graves S.W. 1996 A new interference in some digoxin assays: anti-murine heterophilic antibodies Clinical Pharmacology and Therapeutics 60 593 598
138. Primus F.J. Kalley E.A. Hansen H.J. Goldenberg D.M. 1988 'Sandwich'-type immunoassay of carcinoembryonic antigen in patients receiving murine monoclonal antibodies for diagnosis and therapy Clinical Chemistry 34 261 264
139. Miller J.J. Valdes R. 1991 Approaches to minimizing interference by cross-reacting molecules in immunoassays Clinical Chemistry 37 144 153
140. Clark P.M. Raggatt P.R. Price C.P. 1985 Antibodies interfering in immunometric assays Clinical Chemistry 31 1762
141. Ledermann A. Begent R.H. Bagshawe K.D. Riggs S.J. Searle F. Glaser M.G. Green A.J. Dale R.G. 1988 Repeated antitumour therapy in man with suppression of the host response by cyclosporin A British Journal of Cancer 58 654 657
142. Weiden P.L. Wolf S.B. Breitz H.B. Appelbaum J.W. Seiler C.A. Mallett R. Bjorn M.J. Su F.-M. Fer M.F. Salk D. 1994 Human anti-mouse antibody suppression with cyclosporin A Cancer 73 1093 1097
143. Grebenchtchikov N. Sweep C.G. Geurts-Moespot A. Piffanelli A. Foekens J.A. Benraad ThJ. 2002 An ELISA avoiding interference by heterophilic antibodies in the measurement of components of the plasminogen activation system in blood Journal of Immunological Methods 268 219 231
144. Bowen A.R. Chan Y. Ruddel M.E. Hortin G.L. Csako G. Demosky S.J. Remaley A.T. 2005 Immunoassay interference by a commonly used blood collection tube additive, the organosilicone surfactant SIlwet L-720 Clinical Chemistry 51 1874 1882
145. Chow L. Johnson M. Wells A. Dasgupta A. 2003 Effect of the traditional medicines Chan Su, Lu-Shen-Wan, Dan Shen and Asian ginseng on serum digoxin measurements by immunoassays Journal of Laboratory and Clinical Medicine 17 22 27